59 related articles for article (PubMed ID: 11502731)
1. Modulation of hepatic and renal metabolism and toxicity of trichloroethylene and perchloroethylene by alterations in status of cytochrome P450 and glutathione.
Lash LH; Putt DA; Huang P; Hueni SE; Parker JC
Toxicology; 2007 Jun; 235(1-2):11-26. PubMed ID: 17433522
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-oxidation by CYP2E1 in human liver microsomes.
Real AM; Hong S; Pissios P
Drug Metab Dispos; 2013 Mar; 41(3):550-3. PubMed ID: 23418369
[TBL] [Abstract][Full Text] [Related]
3. Biocatalysis using Thermostable Cytochrome P450 Enzymes in Bacterial Membranes - Comparison of Metabolic Pathways with Human Liver Microsomes and Recombinant Human Enzymes.
Jurva U; Sandinge AS; Baek JM; Avanthay M; Thomson RES; D'Cunha SA; Andersson S; Hayes MA; Gillam EMJ
Drug Metab Dispos; 2024 Feb; 52(3):242-251. PubMed ID: 38176735
[TBL] [Abstract][Full Text] [Related]
4. Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities.
Kim HJ; Lee SH; Koh JS; Lee SH
Bioorg Med Chem Lett; 2012 May; 22(9):3067-71. PubMed ID: 22497764
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants.
Faccioli LAP; Cetin Z; Kocas-Kilicarslan ZN; Ortiz K; Sun Y; Hu Z; Kurihara T; Tafaleng EN; Florentino RM; Wang Z; Xia M; Miedel MT; Taylor DL; Behari J; Ostrowska A; Constantine R; Li A; Soto-Gutierrez A
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686209
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.
Wang Z; Fang Y; Teague J; Wong H; Morisseau C; Hammock BD; Rock DA; Wang Z
Drug Metab Dispos; 2017 Jul; 45(7):712-720. PubMed ID: 28428366
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolic profile and drug-drug interaction assessment of secnidazole, a high-dose 5-nitroimidazole antibiotic for the treatment of bacterial vaginosis.
Pentikis HS; Adetoro N; Kaufman G
Pharmacol Res Perspect; 2020 Aug; 8(4):e00634. PubMed ID: 32776491
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of a Selective Serotonin and Norepinephrine Reuptake Inhibitor Duloxetine in Liver Microsomes and Mice.
Qin X; Hakenjos JM; MacKenzie KR; Barzi M; Chavan H; Nyshadham P; Wang J; Jung SY; Guner JZ; Chen S; Guo L; Krishnamurthy P; Bissig KD; Palmer S; Matzuk MM; Li F
Drug Metab Dispos; 2022 Feb; 50(2):128-139. PubMed ID: 34785568
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and action of proteasome inhibitors in primary human hepatocytes.
Lee CM; Kumar V; Riley RI; Morgan ET
Drug Metab Dispos; 2010 Dec; 38(12):2166-72. PubMed ID: 20837660
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes.
Tang LWT; DaSilva E; Lapham K; Obach RS
Drug Metab Dispos; 2024 May; 52(6):565-573. PubMed ID: 38565303
[TBL] [Abstract][Full Text] [Related]
11. Advances in the study of liver microsomes in the
Sun X; Ye Y; Sun J; Tang L; Yang X; Sun X
Crit Rev Food Sci Nutr; 2024; 64(11):3264-3278. PubMed ID: 36226776
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation research advances - 2022 year in review.
Khojasteh SC; Argikar UA; Cheruzel L; Cho S; Crouch RD; Dhaware D; Heck CJS; Johnson KM; Kalgutkar AS; King L; Liu J; Ma B; Maw H; Miller GP; Seneviratne HK; Takahashi RH; Wang S; Wei C; Jackson KD
Drug Metab Rev; 2023 Nov; 55(4):301-342. PubMed ID: 37737116
[TBL] [Abstract][Full Text] [Related]
13. The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors.
Bergin CJ; Zouggar A; Mendes da Silva A; Fenouil T; Haebe JR; Masibag AN; Agrawal G; Shah MS; Sandouka T; Tiberi M; Auer RC; Ardolino M; Benoit YD
Nat Cancer; 2024 Mar; 5(3):463-480. PubMed ID: 38351181
[TBL] [Abstract][Full Text] [Related]
14. OptoDyCE-plate as an affordable high throughput imager for all optical cardiac electrophysiology.
Heinson YW; Han JL; Entcheva E
J Mol Cell Cardiol Plus; 2023 Dec; 6():. PubMed ID: 38130942
[TBL] [Abstract][Full Text] [Related]
15. Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro.
Zahno A; Brecht K; Bodmer M; Bur D; Tsakiris DA; Krähenbühl S
Br J Pharmacol; 2010 Sep; 161(2):393-404. PubMed ID: 20735423
[TBL] [Abstract][Full Text] [Related]
16. Vanoxerine: cellular mechanism of a new antiarrhythmic.
Lacerda AE; Kuryshev YA; Yan GX; Waldo AL; Brown AM
J Cardiovasc Electrophysiol; 2010 Mar; 21(3):301-10. PubMed ID: 19817928
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
[TBL] [Abstract][Full Text] [Related]
18. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.
Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF
Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
